View Static Version
Loading

Accelerate Blue Fund 2022 Report

I am happy to share this first annual report of the University of Michigan’s Accelerate Blue Fund. This report will show that the Fund is already having a positive impact.

We began our fundraising efforts in 2020, and I am pleased to report that the Accelerate Blue Fund now has over $15 million under management thanks to a combination of donor and university support. The Fund's first investment in Movellus, Inc. was made in May of 2021. Since that time, we have deployed $1.77 million of investment capital into twelve startups. Without our donors and supporters, the success of Accelerate Blue would not have been possible. Thank you!

We have a lot more work to do, but it is worth taking a moment to celebrate the Fund's success, see where we started, how we have done and where we plan to go. The Innovation Partnerships team is excited to leverage the nation’s 3rd largest university research enterprise to launch incredible startups that will create economic opportunity and positive societal impact.

Go Blue!

At Innovation Partnerships, we are honored to support U-M faculty in their efforts to see their research have a positive societal impact through commercialization. The Accelerate Blue Fund is a key component of our ability to enable the launch of high-growth startup companies. By providing patient seed capital to promising U-M startups, Accelerate Blue is unlocking the transformative power of the university’s research engine.

The impact of Accelerate Blue extends well beyond the dollars invested. It has strengthened our office’s ties with the investment community and has helped us to raise the profile of the University of Michigan as a leader in research commercialization.

We are incredibly grateful to the donors and supporters of the Accelerate Blue Fund. Your support has been vital in unlocking this force multiplier for the U-M startup ecosystem. We are well on our way, and look forward to continuing to grow the Fund and its impact with your support.

Sincerely,

"As a leading public research university, it remains incredibly important that society realizes the benefits of our research and scholarship. That means translating ideas, discoveries and technologies from the lab to the marketplace."

- Rebecca Cunningham, M.D., Vice President for Research, University of Michigan

"The Accelerate Blue Fund is the perfect vehicle to create economic opportunity and fuel economic growth. By supporting the Accelerate Blue Fund, we are enabling the university to attract and retain world-class faculty and ensuring that the world benefits from the incredible research and innovation created at the University of Michigan.”

-Rob Bronstein, Co-Founder & President, The Scion Group; Chair, Accelerate Blue Fund Strategic Advisory Board

"Long before we were fundraising, the Ventures team at Innovation Partnerships provided critical mentoring, advice and support to our team. They've been great partners on our entire journey, and we're super grateful for the Accelerate Blue Fund investment and all their help transforming an academic project into a company and product."

-Olivia Walch, Founder and CEO of ABF Portfolio Company Arcascope

Stats and Facts of Fund and Portfolio Performance

$1,774,998 Total Invested by ABF

Current Recognized Valuation - $1,820,684

$44,635,000 Total Raised by Portfolio Companies

Total raised by companies not including ABF investments - $42,860,002

For every $1 of ABF investment, portfolio companies have raised $24 of additional investment capital

Portfolio companies have created 182 jobs in total, of which 146 are in Michigan

Diversity of Company Leadership

11 out of 12 portfolio companies have an underrepresented founder or CEO

Industry Sectors of Portfolio Companies

Semiconductor • Advanced Manufacturing and Additive Manufacturing/or 3D Printing • Sensor - Internet of Things (IOT) - Related to Sensors • Health IT - Sleep Technologies • Cleantech - Carbon Reduction Cleantech and Advanced Materials • AR/VR - Brain Computer Interface and Software • Health IT - CRM • Health IT - Inherited Disease Prediction • Cleantech - Software - Contamination Mitigation • AI • Microfluidic Technology

ABF Strategic Advisory Board

Rob Bronstein - Co-Founder, President, The Scion Group

The Martin Family Foundation - Bill, Sally, Seth and Mike Martin

Ron and Kathy Colby

Amazon Web Services, Inc

Don and Anais Hicks

Richard Douglas and Dr. Anita Kupriss

Don and Erica Sweeney

Toby Brzoznowski - Co-Founder, Chief Strategy Officer, LLamasoft, Inc.

The Bayer Family Foundation - Matt Bayer and Joyce Yaung

Ehrenberg Family Charitable Fund - Roger and Carin Ehrenberg

Melvyn Yeo - Founder, TRIREC

Jonathan C. Oberheide and Ashley N. Oberheide

George and Danielle Skestos

MCRA LLC - Anthony Viscogliosi

Investment Advisory Board

Chris Rizik, Founder & CEO, Renaissance Venture Capital

Christine Gibbons - COO, Fusion Coolant Systems, Inc.

Jay Ellis - Director, Rivian, Inc.

Lisa McLaughlin - Co-Founder, Workit Health, Inc.

Peter Falzon - CEO, Ripple Sciences, Inc.

Felicia David-Visser - Senior Manager, U-M Investment Office

Rafael Castilla - Director of Investments, U-M Investment Office

Mike Klein - CEO, Genomenon, Inc.

Alisyn Malek - Managing Director, Newlab, Inc.

Lara Pender - Partner, Gunderson Dettmer

Adrian Ohmer - Investment Director, The Kresge Foundation

Javier Evelyn - Founder & CEO, Alerje, Inc.

Portfolio Companies

Movellus Circuits provides end-to-end solutions for High Performance and Ultra Low Power SoCs (Systems on Chips).

Closed $23M Series B, ABF participated.

Ulendo provides cloud-based 3D printing software that enables faster and more accurate printing leading to higher quality parts with less waste.

ABF is leading the current pre-seed round.

CubeWorks’ CubiSens™ Platform empowers ubiquitous wireless sensing, smart processing and energy harvesting in millimeter-scale form factors.

Launched CubiSens™ XT1 is a small smart sensor and revolutionary solution for monitoring the temperature of biologics at the product level.

Arcascope makes apps that scientifically track circadian rhythms and generate personalized recommendations.

Recently closed a $2.85M series seed. ABF participated and co-led this round.

NX Fuels provides cost effective, sustainable solutions for production of green fuels from CO2 and water using only renewable solar energy.

Received a federal NSF Phase I grant of $256K and matching state grant from the MEDC ETF $25K, won the DOE's H-Shot award. ABF led the recent series seed.

Ecovia Renewables makes high-performing water soluble and water swellable biopolymers for personal care, agricultural and industrial applications.

ABF participated in the most recent financing.

BlueConduit is a water analytics company providing predictive machine learning software to locate lead service water lines and efficiently replace those pipes.

Supported with $1M in philanthropic funding from the Rockefeller Foundation and $3M from Google.org to address lead water service line challenges in the US. ABF is leading the current pre-seed round.

INHERET is a SaaS solution that identifies patients at increased risk for hereditary diseases.

Launched their online family history and cancer risk interpretation program. ABF is leading the current pre-seed round.

MemryX is a fabless semiconductor company that designs edge AI processing solutions.

Closed a $6M bridge round. ABF participated in the most recent financing.

Mountain Pass offers a faculty management software that brings workflow efficiency and accuracy to medical schools, universities and health systems.

Significant sales growth in 2022 of their faculty position management software that improves workflow efficiency and accuracy to medical schools, universities and health systems.

Neurable provides full-stack neurotechnology tools that interpret human intent, measure emotion and provide telekinetic control of the digital world.

Launched Enten, brain computer interface headphones to improve concentration and focus. Significant retail sale commitments have been signed for 2023 - 2025. ABF participated in the most recent financing.

NewHaptics is a microfluidic technology company that specializes in full-page digital braille and tactile graphics displays.

Received two NSF SBIR Phase II awards totaling $1.7M along with a matching grant of $125,000 from the State of Michigan Emerging Technologies Fund. ABF led the recent pre-seed round.

NextPrevious